Literature DB >> 7430166

Feline sarcoma virus P115-associated protein kinase phosphorylates tyrosine. Identification of a cellular substrate conserved during evolution.

F H Reynolds, W J Van de Ven, J R Stephenson.   

Abstract

The Gardner strain of feline sarcoma virus (FeSV) has previously been shown to encode as its major translational product, a phosphoprotein of molecular weight (Mr) = 115,000 (P115) with an associated protein kinase activity and probable transforming function. In the present study, we demonstrate that this enzyme specifically phosphorylates tyrosine and that Gardner FeSV-transformed mink and rat cells exhibit constitutively higher levels of phosphotyrosine than nontransformed control cells. In addition, we identify a Mr = 150,000 cellular substrate for the FeSV P115-associated protein kinase activity. This latter protein, designated P150, is expressed in cells of a number of mammalian species including cat, mink, dog, rat, mouse and human, possesses broadly reactive interspecies antigenic determinants, and exhibits binding affinity for FeSV P115. Although P150 exhibits an associated protein kinase activity, this activity differs from the FeSV P115-associated enzyme in that it phosphorylates serine and threonine rather than tyrosine. On the basis of immunologic criteria and tryptic peptide analysis, the possibility that P150 is structurally related to Gardner FeSV P115 is excluded. As a consequence of its affinity for FeSV P115, P150 is efficiently incorporated into FeSV pseudotype virions, providing a source for its purification and preparation of antisera for study of its expression in mammalian cells.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7430166

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Monoclonal antibodies specific to transforming polyproteins encoded by independent isolates of feline sarcoma virus.

Authors:  F Veronese; G J Kelloff; F H Reynolds; R W Hill; J R Stephenson
Journal:  J Virol       Date:  1982-09       Impact factor: 5.103

2.  Transforming potential of a human protooncogene (c-fps/fes) locus.

Authors:  J G Sodroski; W C Goh; W A Haseltine
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

3.  Antipeptide antiserum identifies a widely distributed cellular tyrosine kinase related to but distinct from the c-fps/fes-encoded protein.

Authors:  R A Feldman; J P Tam; H Hanafusa
Journal:  Mol Cell Biol       Date:  1986-04       Impact factor: 4.272

4.  Differences in mechanisms of transformation by independent feline sarcoma virus isolates.

Authors:  F H Reynolds; W J Van de Ven; J Blomberg; J R Stephenson
Journal:  J Virol       Date:  1981-06       Impact factor: 5.103

5.  Snyder-Theilen feline sarcoma virus P85 contains a single phosphotyrosine acceptor site recognized by its associated protein kinase.

Authors:  J Blomberg; W J Van de Ven; F H Reynolds; R P Nalewaik; J R Stephenson
Journal:  J Virol       Date:  1981-06       Impact factor: 5.103

6.  New mammalian transforming retrovirus: demonstration of a polyprotein gene product.

Authors:  U R Rapp; F H Reynolds; J R Stephenson
Journal:  J Virol       Date:  1983-03       Impact factor: 5.103

7.  Involvement of a high-molecular-weight polyprotein translational product of Snyder-Theilen Feline sarcoma virus in malignant transformation.

Authors:  F H Reynolds; W J Van de Ven; J Blomberg; J R Stephenson
Journal:  J Virol       Date:  1981-02       Impact factor: 5.103

8.  Evidence that there exist four classes of RNA tumor viruses which encode proteins with associated tyrosine protein kinase activities.

Authors:  T Patschinsky; B M Sefton
Journal:  J Virol       Date:  1981-07       Impact factor: 5.103

9.  The structure of the human c-fes/fps proto-oncogene.

Authors:  A J Roebroek; J A Schalken; J S Verbeek; A M Van den Ouweland; C Onnekink; H P Bloemers; W J Van de Ven
Journal:  EMBO J       Date:  1985-11       Impact factor: 11.598

10.  Virus-specific phosphoproteins in simian sarcoma virus-transformed primate cells.

Authors:  M Born; K von der Helm; F Deinhardt
Journal:  EMBO J       Date:  1982       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.